Official UK procurement notice
Transitional Drugs 5 · UK public procurement notice
Authority: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) (Central government)
What is being bought
Published requirement descriptionThe provision of Drugs that have recently lost exclusivity
- The authority expects to re-tender this requirement around 1 Mar 2027, 23:59 GMT.
CPV: Pharmaceutical products
The lotProcurement structure
single lot · value publishedLot #1AwardedRenewalPublished value£45,077,163
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- Product Quality/Acceptability : Pass/Fail
- Financial (overall cost of contract): Weighting: 85
- Enviromental/Social Value/Community Benefits: Weighting: 15
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- UKPGA · 2023/54 Procurement Act 2023
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Above threshold (FTS publication)
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- Yes · next expected 1 Mar 2027
- First published
- 6 Oct 2025, 15:25 BST
- Last source update
- 29 Jan 2026, 10:47 GMT
- Award evaluation window
- Submission end – 1 Dec 2025
- Authority reference
PHA-FTS-60744- FTS notice number
2025/S 000-066072- Latest notice
- Contract details notice (UK7)
- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-05a8e6Find a Tender
How it was run
Official notice- Submission deadline
- 17 Nov 2025, 10:00 GMT
- Clarification deadline
- 14 Nov 2025, 10:00 GMT
- Submission channel
- Official e-sourcing portal
- Electronic submission
- Allowed
- Accepted languages
- en
Timeline
6 Oct 2025 → 29 Jan 2026 · 11 dates- Planning notice published380 days ago6 Oct 2025, 15:25 BST
- Tender notice published370 days ago16 Oct 2025, 17:07 BST
- Market engagement369 days ago16 Oct 2025, 23:59 BST
This notice is being issued to advise suppliers of a forthcoming opportunity that is due to be published by Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts).
There is no formal engagement process for this opportunity. Any suppliers who may like more information on this opportunity before the tender is published please contact Jen Tresilian ([email protected]).
- Next notice expected368 days ago17 Oct 2025, 23:59 BST
- Clarification questions by341 days ago14 Nov 2025, 10:00 GMT
- Submission deadline338 days ago17 Nov 2025, 10:00 GMT
- Award decision expected by323 days ago1 Dec 2025, 23:59 GMT
- Assessment summaries sent317 days ago8 Dec 2025
- Standstill ends307 days ago17 Dec 2025, 23:59 GMT
- Contract starts293 days ago1 Jan 2026
- Latest notice published265 days ago29 Jan 2026, 10:47 GMT
Notice history
9 events · 4 releases on Find a Tender · since 6 Oct 2025- Preliminary market engagement notice published6 Oct 2025, 15:25 BSTUK2
- Tender notice published16 Oct 2025, 17:07 BSTUK4
- Status changed to active16 Oct 2025, 17:07 BST
- Procurement method changed16 Oct 2025, 17:07 BST
- Deadline published: 17 Nov 2025, 10:00 GMT16 Oct 2025, 17:07 BST
- Contract award notice published8 Dec 2025, 16:23 GMTUK6
- Status changed to complete8 Dec 2025, 16:23 GMT
- Contract signature expected23 Dec 2025, 23:59 GMTscheduled
- Contract details notice published29 Jan 2026, 10:47 GMTUK7
Routine re-releases (4)
- 2025-10: 1 release · 6 Oct 2025
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Janssen-Cilag Ltd, Mercury Pharmaceuticals Limited, Teva UK Ltdjoint award1 Jan 2026 – 31 Dec 2027 · up to 31 Dec 2028Extensions: Extension option available of up to 12 months to 31 December 2028 | £5,577,339 | 25 Nov 2025 | Awarded |
Contracts
Transitional Drugs 5 · Janssen-Cilag Ltd, Mercury Pharmaceuticals Limited, Teva UK Ltd
- Signed
- 31 Dec 2025
- Value
- £5,577,339
- Period
- 1 Jan 2026 – 31 Dec 2027 · up to 31 Dec 2028 with extensions
- Status
- active
- Extensions
- Extension Option of up to 12 months available
No agreed KPIs: No individual supplier's value exceeds the threshold
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 9final-stage tenders | 0 | 0 | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
3 commercial parties on the notice- Janssen LtdAwarded supplier
- Mercury Pharmaceuticals LtdAwarded supplier
- Teva UK LtdAwarded supplier
Official documents & specifications (4)
Official links; attachments are not copiedNotices published for this procedure
- Contract details notice Contract details notice on Find a Tender
- Contract award notice Contract award notice on Find a Tender
- Tender notice Tender notice on Find a Tender
- Preliminary market engagement notice Preliminary market engagement notice on Find a Tender